multiple dose bioequivalence study [Design Issues]

posted by Loky do – Egypt, 2020-08-09 11:50 (404 d 04:29 ago) – Posting: # 21842
Views: 1,788

Dears

If we have solifenacin 6 mg (immediate-release) / tamsulosin 0.4 mg modified-release product combination, is multiple-dose bioequivalence study required to be submitted to the European authorities in addition to fast & fed studies, as there is no specific guidance for this product & in GCC region fast & fed studies only accepted.

Thanks in advance

Complete thread:

Activity
 Admin contact
21,684 posts in 4,534 threads, 1,541 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time: Friday 16:20 CEST (Europe/Vienna)

Genius is that which forces
the inertia of humanity to learn.    Henri Bergson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5